[at noodls] – Provides Full Year 2013 Guidance Fourth quarter and full year 2012 revenue of $18.6 million and $76.2 million, respectively, compared to $18.8 and $68.1 million for the fourth quarter and full year 2011, … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboardSee who ZELTIQ is hiring next, click […]
[at noodls] – PLEASANTON, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) — ZELTIQ Aesthetics, Inc. (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboardSee who ZELTIQ is hiring next, click here to view […]
[at noodls] – PLEASANTON, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) — ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboardSee who ZELTIQ is hiring next, click here to view […]
[at noodls] – PLEASANTON, Calif., Nov. 28, 2012 (GLOBE NEWSWIRE) — ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – PLEASANTON, Calif., Oct. 18, 2012 (GLOBE NEWSWIRE) — ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Third Quarter Highlights Revenues of $17.9 million, compared to $17.7 million for the third quarter of 2011 77,500 cycles shipped, up 73.7% from the third quarter of 2011 Procedure fee revenues accounted … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – CTO and SVP of Worldwide Sales Bring Significant Experience Developing and Commercializing Successful Aesthetic Devices PLEASANTON, Calif., Oct. 16, 2012 (GLOBE NEWSWIRE) — ZELTIQ Aesthetics, Inc. (Nasdaq:ZLTQ), … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – World Renowned Dermatologist Dr. Henry Chan Performing Live CoolSculpting Demonstration with CoolCurve+ ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology company focused on developing and commercializing … moreView todays social media effects on ZLTQView the latest stocks trending across Twitter. Click to view dashboard […]
